MA37927B2 - Dérivés isoxazolidine - Google Patents

Dérivés isoxazolidine

Info

Publication number
MA37927B2
MA37927B2 MA37927A MA37927A MA37927B2 MA 37927 B2 MA37927 B2 MA 37927B2 MA 37927 A MA37927 A MA 37927A MA 37927 A MA37927 A MA 37927A MA 37927 B2 MA37927 B2 MA 37927B2
Authority
MA
Morocco
Prior art keywords
isoxazolidine derivatives
relates
compounds
isoxazolidine
derivatives
Prior art date
Application number
MA37927A
Other languages
English (en)
Other versions
MA20150350A1 (fr
Inventor
Eleonora Ghidini
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47044778&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA37927(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of MA20150350A1 publication Critical patent/MA20150350A1/fr
Publication of MA37927B2 publication Critical patent/MA37927B2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0068—Nitrogen and oxygen at position 16(17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Otolaryngology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

La présente invention concerne de nouveaux composés anti-inflammatoires et antiallergiques de la série des glucocorticostéroïdes, des méthodes de préparation de ces composés, des compositions pharmaceutiques les comprenant, des combinaisons et des usages thérapeutiques de ceux-ci. Plus particulièrement, l'invention porte sur des glucocorticostéroïdes qui sont des dérivés isoxazolidine.
MA37927A 2012-09-13 2013-08-23 Dérivés isoxazolidine MA37927B2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12184286 2012-09-13
PCT/EP2013/067509 WO2014040837A1 (fr) 2012-09-13 2013-08-23 Dérivés isoxazolidine

Publications (2)

Publication Number Publication Date
MA20150350A1 MA20150350A1 (fr) 2015-10-30
MA37927B2 true MA37927B2 (fr) 2021-08-31

Family

ID=47044778

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37927A MA37927B2 (fr) 2012-09-13 2013-08-23 Dérivés isoxazolidine

Country Status (28)

Country Link
US (2) US9155747B2 (fr)
EP (1) EP2895495B1 (fr)
JP (2) JP2015533801A (fr)
KR (1) KR101719524B1 (fr)
CN (2) CN108440637A (fr)
AR (1) AR092547A1 (fr)
AU (1) AU2013314539B2 (fr)
BR (1) BR112015005500B1 (fr)
CA (1) CA2884705C (fr)
CL (1) CL2015000610A1 (fr)
EA (1) EA027034B1 (fr)
ES (1) ES2672140T3 (fr)
GE (1) GEP201706708B (fr)
HK (1) HK1209756A1 (fr)
IL (1) IL237686A (fr)
MA (1) MA37927B2 (fr)
MX (1) MX364865B (fr)
MY (1) MY182523A (fr)
NZ (1) NZ705902A (fr)
PE (1) PE20150675A1 (fr)
PH (1) PH12015500534B1 (fr)
PL (1) PL2895495T3 (fr)
SA (1) SA515360134B1 (fr)
SG (1) SG11201501902RA (fr)
TN (1) TN2015000093A1 (fr)
UA (1) UA116545C2 (fr)
WO (1) WO2014040837A1 (fr)
ZA (1) ZA201501691B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6053700B2 (ja) 2011-03-15 2016-12-27 シエシー ファルマセウティチィ ソシエタ ペル アチオニ イソオキサゾリジン誘導体
CN114748622A (zh) 2017-10-05 2022-07-15 弗尔康医疗公司 P38激酶抑制剂降低dux4和下游基因表达以用于治疗fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31997A (en) * 1968-05-03 1974-03-14 Lepetit Spa Process for the preparation of pregnano(17alpha,16alpha-d)oxazolines and 16alpha,21-dihydroxy-17alpha-aminopregnanes
SE378110B (fr) * 1972-05-19 1975-08-18 Bofors Ab
JPS617293A (ja) * 1984-06-20 1986-01-13 Mitsubishi Chem Ind Ltd 新規なコルチコイド誘導体およびその製法
US5888995A (en) * 1991-02-04 1999-03-30 Astra Aktiebolag Steroid esters
WO2003070745A2 (fr) * 2002-02-20 2003-08-28 Sepracor Inc. Formes modifiees de carbonate et de carbamate de glucocorticoides
WO2005028495A1 (fr) * 2003-09-24 2005-03-31 Glaxo Group Limited Glucocorticoïdes anti-inflammatoires
NO331891B1 (no) * 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
JP2011513303A (ja) * 2008-02-27 2011-04-28 アストラゼネカ・アクチエボラーグ １６アルファ，１７アルファ−アセタールグルココルチコステロイド誘導体およびその使用
CN105175479B (zh) 2009-09-11 2017-06-09 奇斯药制品公司 异噁唑烷衍生物
TW201139369A (en) 2010-02-05 2011-11-16 Chiesi Farma Spa Pyrrolidine derivatives
JP6053700B2 (ja) 2011-03-15 2016-12-27 シエシー ファルマセウティチィ ソシエタ ペル アチオニ イソオキサゾリジン誘導体
BR112013022890A2 (pt) 2011-03-15 2016-09-13 Chiesi Farma Spa composto, composição farmacêutica, combinação e uso de um composto
EP2739640A1 (fr) * 2011-08-01 2014-06-11 Chiesi Farmaceutici S.p.A. Stéroïdes anti-inflammatoires condensés en position 16,17 avec un cycle pyrrolidine

Also Published As

Publication number Publication date
ZA201501691B (en) 2016-10-26
GEP201706708B (en) 2017-07-25
JP2018162270A (ja) 2018-10-18
US9469669B2 (en) 2016-10-18
MA20150350A1 (fr) 2015-10-30
IL237686A (en) 2017-10-31
BR112015005500A2 (pt) 2018-05-22
CA2884705C (fr) 2021-04-13
EP2895495A1 (fr) 2015-07-22
US20150376226A1 (en) 2015-12-31
PH12015500534A1 (en) 2015-05-04
HK1209756A1 (en) 2016-04-08
AR092547A1 (es) 2015-04-22
TN2015000093A1 (en) 2016-06-29
NZ705902A (en) 2018-04-27
EA027034B1 (ru) 2017-06-30
PE20150675A1 (es) 2015-05-20
CN104619714A (zh) 2015-05-13
US20140069419A1 (en) 2014-03-13
WO2014040837A1 (fr) 2014-03-20
BR112015005500B1 (pt) 2022-11-22
CN108440637A (zh) 2018-08-24
PL2895495T3 (pl) 2018-10-31
MX2015002898A (es) 2015-06-03
JP2015533801A (ja) 2015-11-26
CA2884705A1 (fr) 2014-03-20
SA515360134B1 (ar) 2016-07-24
KR101719524B1 (ko) 2017-03-24
UA116545C2 (uk) 2018-04-10
AU2013314539A1 (en) 2015-04-02
EP2895495B1 (fr) 2018-05-16
SG11201501902RA (en) 2015-04-29
CL2015000610A1 (es) 2015-12-04
US9155747B2 (en) 2015-10-13
MX364865B (es) 2019-05-09
MY182523A (en) 2021-01-25
ES2672140T3 (es) 2018-06-12
KR20150042264A (ko) 2015-04-20
JP6736607B2 (ja) 2020-08-05
AU2013314539B2 (en) 2018-03-08
PH12015500534B1 (en) 2015-05-04
EA201590390A1 (ru) 2015-08-31

Similar Documents

Publication Publication Date Title
MA33561B1 (fr) Dérivés d'isoxazolidine
MA37206B1 (fr) Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EA201691070A1 (ru) Новые трициклические соединения в качестве противораковых средств
EA201591404A1 (ru) Спиролактамные модуляторы рецептора nmda и их применение
AU2012253757A8 (en) Partially saturated tricyclic compounds and methods of making and using same
EA201001639A1 (ru) Композиции и способы их получения и применения
MA35816B1 (fr) Dérivés d'aniline, leur préparation et leur application thérapeutique
MA32811B1 (fr) Nouveaux composés
UA118332C2 (uk) Білок, що зв'язує антиген cd27l
UY29079A1 (es) Acidos fenoxiacéticos sustituidos, composiciones que los contienen, procedimientos de preparación y aplicaciones
MA40875A (fr) 2,4-diamino-quinoléine substituée servant de nouveaux agents anticancéreux
EA201401193A1 (ru) Триарильные соединения и композиции, их содержащие
GB2511685A (en) Muscarinic m1 receptor agonists
UA109260C2 (uk) Хромонові похідні, спосіб їх одержання та їх терапевтичні застосування
CY1122441T1 (el) Καινοτομες ενωσεις και συζευγματα κρυπτοφυκινης, η παρασκευη τους και η θεραπευτικη χρηση τους
MY183111A (en) 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
EA201170421A1 (ru) N-сульфонамидопиразолильные полициклические соединения
EA200970849A1 (ru) Трициклические производные изохинолина для лечения ожирения
MA32945B1 (fr) Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutique
TN2013000313A1 (en) Isoxazolidine derivatives
MA37927B2 (fr) Dérivés isoxazolidine
CY1116158T1 (el) Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
ATE523188T1 (de) Parfümierungsnitrile
WO2012123493A3 (fr) Dérivés d'isoxazolidine
MA43158B1 (fr) Composés oxa-diazadispiro possédant une activité contre la douleur